Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
D000740:Anemia / Q000139:chemically induced; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons